[The good, the bad, the ugly] Editor's Review week of February 29

from Off Script: A Pharma Manufacturing Podcast · host Pharma Manufacturing

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Iovance has launches Amtagvi The bad — FDA rejected Theratechnologies HIV instramuscular injection The ugly — BioMarin receives a subpoena from the DOJ

What this episode covers

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Iovance has launches AmtagviThe bad — FDA rejected Theratechnologies HIV instramuscular injectionThe ugly — BioMarin receives a subpoena from the DOJ

NOW PLAYING

[The good, the bad, the ugly] Editor's Review week of February 29

0:00 3:07

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Off Script: A Pharma Manufacturing Podcast?

This episode is 3 minutes long.

When was this Off Script: A Pharma Manufacturing Podcast episode published?

This episode was published on March 5, 2024.

What is this episode about?

Can I download this Off Script: A Pharma Manufacturing Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!